Skip to main content

Recent Progress in Research on the Pharmacological Potential of Mushrooms and Prospects for Their Clinical Application

  • Chapter
  • First Online:
Book cover Medicinal Mushrooms

Abstract

Fungi are considered one of the most diverse, ecologically significant, and economically important organisms on Earth. The edible and medicinal mushrooms have long been known by humans and were used by ancient civilizations not only as valuable food but also as medicines. Mushrooms are producers of high- and low-molecular-weight bioactive compounds (alkaloids, lectins, lipids, peptidoglycans, phenolics, polyketides, polysaccharides, proteins, polysaccharide-protein/peptides, ribosomal and non-ribosomal peptides, steroids, terpenoids, etc.) possessing more than 130 different therapeutic effects (analgesic, antibacterial, antifungal, anti-inflammatory, antioxidant, antiplatelet, antiviral, cytotoxic, hepatoprotective, hypocholesterolemic, hypoglycemic, hypotensive, immunomodulatory, immunosuppressive, mitogenic/regenerative, etc.).

The early record of Materia Medica shows evidence of using mushrooms for treatment of different diseases. Mushrooms were widely used in the traditional medicine of many countries around the world and became great resources for modern clinical and pharmacological research. However, the medicinal and biotechnological potential of mushrooms has not been fully investigated. This review discusses recent advances in research on the pharmacological potential of mushrooms and perspectives for their clinical application.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ACE:

Angiotensin-converting enzyme

AIDS:

Acquired immune deficiency syndrome

BDNF:

Brain-derived neurotrophic factor

CL:

Cultural liquid

COX-1:

Cyclooxygenase-1

COX-2:

Cyclooxygenase-2

CSF:

Colony-stimulating factor

CVD:

Cardiovascular diseases

DENV-2:

Dengue virus type 2

DS:

Dietary supplement

EPS:

Exopolysaccharides

FIP:

Fungal immunomodulatory protein

GLPS:

G. lucidum polysaccharide

GSK-3:

Glycogen synthase kinase 3

HIV:

Human immunodeficiency virus

HK2:

Hexokinase 2

HMG-CoA:

5-Hydroxy-3-methylglutaryl-coenzyme A

HPV-1:

Human papillomavirus 1

HSV-2:

Herpes simplex virus 2

IC50:

The half maximal inhibitory concentration

IFN:

Interferon

IL:

Interleukin

iNOS:

Inducible NO synthase

LPS:

Lipopolysaccharide

MDCK:

Madin-Darby canine kidney cells

MIC:

Minimal inhibitory concentrations

MMDD:

Medicinal mushroom-derived drug

MS:

Mycosterol

NGF:

Nerve growth factor

NO:

Nitric oxide

NSAID:

Nonsteroidal anti-inflammatory drug

OLTT:

Oxygenated lanostane-type triterpenoid

PAMP:

Pathogen-associated molecular pattern

PPAR:

Peroxisome proliferator-activated receptor

PRR:

Pattern recognition receptor

PI3K/Akt:

Phosphatidylinositol-3-kinase and protein kinase B

PSK:

Polysaccharide K

PSP:

Polysaccharide-protein

PSPC:

Polysaccharide-protein complex

PTP1B:

Protein tyrosine phosphatase 1B

QoL:

Quality of life

STAT3:

Signal transducer and activator of transcription 3

TCM:

Traditional Chinese medicine

TNBC:

Triple-negative breast cancer

TNF:

Tumor necrosis factor

TNFα:

Tumor necrosis factor alfa

VDM:

Vitamin D-enriched mushroom

References

Download references

Acknowledgments

This chapter arises from a long-standing cooperation between two authors (S.M.B. and S.R.) on fungal research directed to the identification of bioactive compounds and medicinal properties supported by the collaboration between the Institute of Pharmacy; Yerevan State University, Armenia; and Faculty of Pharmacy of the University of Montpellier/UMR 5175 CNRS, France.

We thank Philippe Callac (INRA, Villenave d’Ornon, France) for advice on the genus Agaricus. We are grateful to our colleagues Claudio Angelini (Pordenone, Italy), Guy Fourré (France), Jacques Guinberteau (France), Jean-Paul Maurice (Société Lorraine de Mycologie, Neufchâteau, France), Jean-Marc Moingeon (Goux-les-Usiers, France), Luigi Perrone (Roma, Italy), Jean-Philippe Rioult (EREM, Caen, France), and Peter Verstraeten (Nazareth, Belgium) for kindly providing photos of medicinal mushrooms (Figs. 1.1 and 1.2). We are also very thankful to mycologists and researchers around the world for providing literature data.

The authors have not reported any conflict of interest that would likely raise questions about their independence.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanna M. Badalyan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Badalyan, S.M., Barkhudaryan, A., Rapior, S. (2019). Recent Progress in Research on the Pharmacological Potential of Mushrooms and Prospects for Their Clinical Application. In: Agrawal, D., Dhanasekaran, M. (eds) Medicinal Mushrooms. Springer, Singapore. https://doi.org/10.1007/978-981-13-6382-5_1

Download citation

Publish with us

Policies and ethics